☆ 4.6 Article

COVID-19 outcomes in patients with cancer: Findings from the University of California health system database

CANCER MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Virology

The outcome of COVID-19 in patients with hematological malignancy

Tugce N. Yigenoglu et al.

Summary: This study shows that patients with hematological malignancy have a higher risk of COVID-19-related severe events compared to those without cancer, with higher rates of ICU admission, mechanical ventilation support, and death. It confirms the heightened vulnerability of patients with hematological malignancy during the current pandemic.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Dermatology

Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study

Ahmed Yousaf et al.

Summary: This study suggests that patients with recent TNFi or methotrexate exposure do not have increased hospitalization or mortality compared with patients with COVID-19 without recent TNFi or methotrexate exposure.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection

Article Oncology

Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study

Nathanael R. Fillmore et al.

Summary: The study found that COVID-19 infection rates and outcomes in cancer patients are influenced by various factors such as race, cancer type, age, and comorbidities. The presence of cancer itself affects susceptibility and eventual outcomes. However, race and recent treatments (including immunotherapy) do not impact outcomes of COVID-19.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Letter Oncology

COVID-19 and myeloproliferative neoplasms: some considerations

Baransel Kamaz et al.

LEUKEMIA (2021)

Add to Collection

Letter Rheumatology

Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland

Aron Hjalti Bjornsson et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Oncology

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

QuanQiu Wang et al.

Summary: This case-control study found that patients with recent cancer diagnosis were at significantly increased risk for COVID-19 infection and its adverse outcomes, with the strongest association for leukemia, non-Hodgkin lymphoma, and lung cancer. African American cancer patients had a higher risk of COVID-19 infection compared to White patients, highlighting the need for better protection and monitoring strategies.

JAMA ONCOLOGY (2021)

Add to Collection

Article Oncology

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm

Richard A. Salisbury et al.

LEUKEMIA (2021)

Add to Collection

Review Oncology

Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis

Zhixian Lin et al.

Summary: The study concluded through meta-analysis of 26 studies that anti-cancer therapies such as surgery, chemotherapy, immunotherapy, and targeted therapy are not associated with disease severity or mortality in cancer patients with COVID-19. Further research is needed to explore the complex relationship between anti-cancer therapy, especially chemotherapy, and COVID-19.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

Add to Collection

Article Oncology

COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway

Tom Borge Johannesen et al.

Summary: In this study, researchers aimed to identify factors associated with higher risk of COVID-19 and adverse outcomes among cancer patients. The study found that cancer patients had similar age-adjusted rates of COVID-19 as the general population. Patients who had undergone major surgery within the past 3 months had an increased risk of COVID-19, but no increased risk was found for other oncological treatment modalities. Patients with distant metastases had a significantly increased risk of death due to COVID-19.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas et al.

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience

Abdul Waris et al.

Summary: By analyzing the blood parameters of COVID-19 patients, it was found that WBC and granulocyte counts were significantly increased in the severe group, while platelet and lymphocyte counts decreased. Blood parameters such as NLR, PLR, and LMR can be used as suitable biomarkers for the prognosis and severity of COVID-19.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Add to Collection

Article Oncology

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

Noha Sharafeldin et al.

Summary: The largest multicenter cohort of cancer patients with COVID-19 to date was constructed by the U.S. N3C collaboration. It was found that COVID-19 positivity significantly increased the risk of all-cause mortality in cancer patients. Factors such as age, gender, region, comorbidities, and specific cancer types were associated with increased mortality risk in cancer patients with COVID-19.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection

Lindsay A. Thompson et al.

Summary: An analysis of the association between allergy medications and SARS-CoV-2 testing results found that certain allergy medications may be linked to negative test results, but this association may be influenced by selection bias. Therefore, caution is needed when interpreting the impact of allergy medications on SARS-CoV-2 testing outcomes.

ECLINICALMEDICINE (2021)

Add to Collection

Article Oncology

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

J. Rogado et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020

Nancy Chow et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Hematology

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti et al.

LANCET HAEMATOLOGY (2020)

Add to Collection

Review Hematology

Coagulopathy in COVID-19

Toshiaki Iba et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Letter Oncology

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Moritz Fuerstenau et al.

LEUKEMIA (2020)

Add to Collection

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Add to Collection

Review Oncology

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

Emre Yekeduz et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Review Hematology

Thrombosis risk associated with COVID-19 infection. A scoping review

Fatimah Al-Ani et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Oncology

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Justin Jee et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

Julio Garcia-Suarez et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Stephanie L. Harrison et al.

PLOS MEDICINE (2020)

Add to Collection

Article Oncology

Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy

Alexia Francesca Bertuzzi et al.

CANCERS (2020)

Add to Collection

Article Infectious Diseases

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study

Jing Gong et al.

BMC INFECTIOUS DISEASES (2020)

Add to Collection

Review Medicine, General & Internal

Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis

Shirley Sze et al.

ECLINICALMEDICINE (2020)

Add to Collection

Review Oncology

Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data

Vassilis G. Giannakoulis et al.

JCO GLOBAL ONCOLOGY (2020)

Add to Collection

Review Infectious Diseases

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

M. Reinwald et al.

CLINICAL MICROBIOLOGY AND INFECTION (2018)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Adjust for Multiple Comparisons? It's Not That Simple

Andrew D. Althouse

ANNALS OF THORACIC SURGERY (2016)

Add to Collection

Review Cell Biology

Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation

Sylvie Hermouet et al.

MEDIATORS OF INFLAMMATION (2015)

Add to Collection

Article Statistics & Probability

mice: Multivariate Imputation by Chained Equations inR

Stef van Buuren et al.

Journal of Statistical Software (2015)

Add to Collection

Article Hematology

Myeloproliferative disorders: complications, survival and causes of death

S Brodmann et al.

ANNALS OF HEMATOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.